PAI1 mediates fibroblast-mast cell interactions in skin fibrosis
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Fibrosis is a prevalent pathological condition arising from the chronic activation of fibroblasts. This activation results from the extensive intercellular crosstalk mediated by both soluble factors and direct cell-cell connections. Prominent among these are the interactions of fibroblasts with immune cells, in which the fibroblast-mast cell connection, although acknowledged, is relatively unexplored. We have used a Tg mouse model of skin fibrosis, based on expression of the transcription factor Snail in the epidermis, to probe the mechanisms regulating mast cell activity and the contribution of these cells to this pathology. We have discovered that Snail-expressing keratinocytes secrete plasminogen activator inhibitor type 1 (PAI1), which functions as a chemotactic factor to increase mast cell infiltration into the skin. Moreover, we have determined that PAI1 upregulates intercellular adhesion molecule type 1 (ICAM1) expression on dermal fibroblasts, rendering them competent to bind to mast cells. This heterotypic cell-cell adhesion, also observed in the skin fibrotic disorder scleroderma, culminates in the reciprocal activation of both mast cells and fibroblasts, leading to the cascade of events that promote fibrogenesis. Thus, we have identified roles for PAI1 in the multifactorial program of fibrogenesis that expand its functional repertoire beyond its canonical role in plasmin-dependent processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, mast cells can directly interact with skin (myo) fibroblasts, and this facilitates their role in fibrosis.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
The cited source says what the claim attributes to it.
In the citing paper
“Apart from the aforementioned role as inhibitor of plasmin activation, this protein is a chemotactic for mast cells and induces the expression of intercellular adhesion molecule 1 (ICAM1) in fibroblasts, which is needed for mast cells to adhere to fibroblasts (162).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
In the citing paper
“This interaction was shown to be serpine1 dependent.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“Consequently, fibrosis is often associated with cancer (2), scleroderma (3), and numerous other connective tissue disorders (4, 5).”
BackgroundRGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“Interestingly, the LDV peptides can be recognized by integrins (59).”
BackgroundChemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059 · cited 1×
“These cytokines have also been implicated in neutrophil, NK cell, and T cell migration and activation (66).”
BackgroundTargeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · cited 2×
“The existence of these simultaneously operating mechanisms makes it evident why inhibitors of IL-4 or TGF-β alone are yielding disappointing results as antifibrotic targets in clinical trials (33, 34).”
BackgroundMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392 · cited 1×
“Various cells including neutrophils (6), macrophages (7), and mast cells (8, 9) have been shown to be sources of a number of fibroblast-activating cytokines and/or chemokines.”
BackgroundHenderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Ghosh, A. K., & Vaughan, D. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 679 · cited 10×
“Consistent with these observations, the removal of Pai1 has also been shown to rescue the disease phenotype (22, 26, 27).”
BackgroundMethodResultInfluentialThe serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Cited by
Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring
El Ayadi, A., Jay, J. W., & Prasai, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031105 · Cited by 246
“A very recent report showed that PAI-1 regulates fibrosis by mediating the effects of mast cells on fibroblasts, therefore regulating collagen secretion by these cells [174].”
BackgroundDiet and Skin Aging—From the Perspective of Food Nutrition
Cao, C., Xiao, Z., Wu, Y., & Ge, C. (2020) · Nutrients · doi:10.3390/nu12030870 · Cited by 231
“Fibroblasts are also involved in skin aging [8], carcinogenesis [9], wound healing [10], fibrosis [11], and other pathological processes.”
BackgroundThe immunopathogenesis of fibrosis in systemic sclerosis
Brown, M., & O’Reilly, S. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13238 · Cited by 190
Pathophysiology of systemic sclerosis (scleroderma)
Rosendahl, A., Schönborn, K., & Krieg, T. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12505 · Cited by 160
“Mast cells are attracted into fibrotic lesions by local PAI (plasminogen activator inhibitor) signaling stemming from epidermal keratinocytes.(42) Their infiltration can precede the first pathological”
BackgroundUnraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Di Gregorio, J., Robuffo, I., Spalletta, S., Giambuzzi, G., De Iuliis, V., Toniato, E., Martinotti, S., Conti, P., & Flati, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607483 · Cited by 145
“In particular, high PAI-1 levels have been found in skin fibrosis where PAI-1 promotes mast cells-fibroblasts contact and may act as a molecule that conveys mast cells to the tissue site (Pincha et al., 2018).”
BackgroundFibroblasts as confederates of the immune system
Correa‐Gallegos, D., Jiang, D., & Rinkevich, Y. (2021) · Immunological Reviews · doi:10.1111/imr.12972 · Cited by 136
Scars or Regeneration?—Dermal Fibroblasts as Drivers of Diverse Skin Wound Responses
Jiang, D., & Rinkevich, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020617 · Cited by 126
“and mast cells [66], and results in activation of both fibroblasts and adhered leukocytes, amplifying the fibrotic response.”
BackgroundEvolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Korman, B. D. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.010 · Cited by 93
Cutaneous immune responses mediated by dendritic cells and mast cells
Sumpter, T. L., Balmert, S. C., & Kaplan, D. H. (2019) · JCI Insight · doi:10.1172/jci.insight.123947 · Cited by 67
Bao, Q., Zhang, B., Suo, Y., Liu, C., Yang, Q., Zhang, K., Yuan, M., Yuan, M., Zhang, Y., & Li, G. (2020) · eLife · doi:10.7554/elife.49923 · Cited by 63
RETRACTED: Mast Cells in Skin Scarring: A Review of Animal and Human Research
Ud‐Din, S., Wilgus, T. A., & Bayat, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552205 · Cited by 63
“A Snail-Tgmouse model of skin fibrosis has been used to investigate the mechanisms regulating mast cell activity (74).”
MethodRetractedInnate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
Laurent, P., Sisirak, V., Lazaro, E., Richez, C., Duffau, P., Blanco, P., Truchetet, M., & Contin‐Bordes, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01702 · Cited by 68
“Furthermore, a recent report using transgenic mice that develop spontaneous skin fibrosis showed a major role for mast cells specifically in inducing inflammation of the skin and the production of ECM and α-SMA by fibroblasts (50).”
BackgroundA Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
Wilgus, T. A., Ud‐Din, S., & Bayat, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249673 · Cited by 61
“In vitro studies showed that PAI-1 stimulated mast cell chemotaxis and promoted mast cell-fibroblast interactions by increasing focal adhesion kinase signaling and enhancing the surface expression of intercellular adhesion molecule-1 [116].”
BackgroundGeng, X., Li, L., Luo, Y., Yang, W., Hu, J., Zhao, Z., Cheng, C., Zhang, T., Zhang, Y., Liu, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202203324 · Cited by 57
Mast cells and collagen fibrillogenesis
Atiakshin, D., Buchwalow, I., & Tiemann, M. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01875-9 · Cited by 49
Proteoglycan 4 (PRG4) treatment enhances wound closure and tissue regeneration
Krawetz, R. J., Abubacker, S., Leonard, C. A., Masson, A. O., Shah, S., Narendran, N., Tailor, P., Regmi, S. C., Labit, E., Ninkovic, N., et al. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00228-5 · Cited by 46
Durant, F., & Whited, J. L. (2021) · Advanced Science · doi:10.1002/advs.202100407 · Cited by 46
Xu, M., Warner, C., Duan, X., Cheng, Z., Jeyarajan, A. J., Li, W., Wang, Y., Shao, T., Salloum, S., Chen, P., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.026 · Cited by 48
Mast cells: a double-edged sword in inflammation and fibrosis
Wang, X., Zhang, P., Tang, Y., Chen, Y., Zhou, E., & Gao, K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1466491 · Cited by 41
Zhao, W., Zhang, H., Liu, R., & Cui, R. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s412717 · Cited by 36
“Cell-cell gap junction formed between fibroblasts and MC, the structural basis for the role of MC, enhanced the contact of cells, thus promoting the growth, proliferation, migration, and differentiation of fibroblasts.(99,100) Therefore, eliminating the gap connection between them may play a role in preventing scarrin…”
BackgroundImmunomodulatory hydrogels for skin wound healing: cellular targets and design strategy
He, Y., Cen, Y., & Tian, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02626d · Cited by 37
Advances in scarless foetal wound healing and prospects for scar reduction in adults
Yin, J., Wu, Y., Yuan, Z., Gao, X., & Chen, H. (2020) · Cell Proliferation · doi:10.1111/cpr.12916 · Cited by 38
Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
Zhang, Q., Lu, C., Lu, F., Liao, Y., Cai, J., & Gao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1365156 · Cited by 33
Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice
Imai, J., Yahata, T., Ichikawa, H., Ibrahim, A. A., Yazawa, M., Sumiyoshi, H., Inagaki, Y., Matsushima, M., Suzuki, T., Mine, T., et al. (2020) · Intestinal Research · doi:10.5217/ir.2019.00037 · Cited by 28
Strattan, E., Palaniyandi, S., Kumari, R., Du, J., Hakim, N., Huang, T., Kesler, M., JENNINGS, C. D., Sturgill, J., & Hildebrandt, G. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02470 · Cited by 25
Tsai, C., Hsieh, S., Wu, T.-H., Li, K., Shen, C., Liao, H., Wu, C.-H., Kuo, Y., Lu, C.-S., & Yu, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093069 · Cited by 26
“Many different immune-related cells such as M2 macrophages [91,92], dendritic cells (DCs) [92,93], mast cells [94], neutrophils [95], B lymphocytes [96,97], T lymphocytes [98,99], innate lymphoid cells [100], endothelial cells [101], platelets [14,102], adipocytes [103], and keratinocytes [104] are involved in the mod…”
BackgroundRationally-based therapeutic disease modification in systemic sclerosis: Novel strategies
Asano, Y., & Varga, J. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.007 · Cited by 24
Xing, X., Xu, Z., Chen, L., Jin, S., Zhang, C., & Xiang, L. F. (2021) · Experimental Dermatology · doi:10.1111/exd.14509 · Cited by 23
Immunomodulatory Significance of Mast Cell Exosomes (MC-EXOs) in Immune Response Coordination
Komi, D. E. A., Shafaghat, F., Alipoor, S. D., Kazemi, T., Atiakshin, D., Pyatilova, P., & Maurer, M. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09033-6 · Cited by 27
“Activated fibroblasts exhibit increased expression of α-smooth muscle actin (α-SMA), a marker associated with tissue fibrosis [118, 119].”
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 26
Jin, Y., Liang, Z.-Y., Zhou, W., & Zhou, L. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190560 · Cited by 21
Adult Renal Stem/Progenitor Cells Can Modulate T Regulatory Cells and Double Negative T Cells
Curci, C., Picerno, A., Chaoul, N., Stasi, A., Palma, G. D., Franzin, R., Pontrelli, P., Castellano, G., Pertosa, G. B., Macchia, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010274 · Cited by 22
“Finally, PAI1, which is also called Serpin E1, functions as a chemotactic factor of mast cells and upregulating intercellular adhesion molecule type 1 (ICAM1) expression during inflammation [48].”
BackgroundGonzález‐Barrio, D., Diezma‐Díaz, C., Gutiérrez-Expósito, D., Tabanera, E., Jiménez‐Meléndez, A., Pizarro, M., González‐Huecas, M., Ferre, I., Ortega‐Mora, L. M., & Álvarez‐García, G. (2021) · Veterinary Research · doi:10.1186/s13567-021-00974-2 · Cited by 20
“In several studies, PLAT expression was mainly inhibited by plasminogen activator inhibitor-1 (PAI-1), and it is suggested that PAI-1 promotes pathological fibrosis [39, 40] and also regulates ICAM1 by increasing its expression [41].”
BackgroundBadarinath, K., Dam, B., Kataria, S., Zirmire, R. K., Dey, R., Kansagara, G., Ajnabi, J., Hegde, A., Singh, R., Masudi, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111390 · Cited by 18
Self-citationHyperforin regulates renal fibrosis via targeting the PI3K-AKT/ICAM1 axis
Yang, S., Zhong, S., Deng, Z., Xie, T., Yin, G., Wang, L., Liu, J., Yang, J., Long, Z., Jiang, X., et al. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110691 · Cited by 16
Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic Sclerosis
Rana, I., Kataria, S., Tan, T. L., Hajam, E. Y., Kashyap, D. K., Saha, D., Ajnabi, J., Paul, S., Jayappa, S., Ananthan, A. S., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.10.011 · Cited by 18
Self-citationEmerging Role of the Mast Cell–Microbiota Crosstalk in Cutaneous Homeostasis and Immunity
Bosveld, C. J., Guth, C. R., Limjunyawong, N., & Pundir, P. (2023) · Cells · doi:10.3390/cells12222624 · Cited by 15
Activation of Fibroblast Contractility via Cell-Cell Interactions and Soluble Signals
Pincha, N., Saha, D., Bhatt, T., Zirmire, R. K., & Jamora, C. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3021 · Cited by 13
Self-citationTomita, N., Hotta, Y., Naiki‐Ito, A., Hirano, K., Kataoka, T., Maeda, Y., Takahashi, S., & Kimura, K. (2020) · Physiological Reports · doi:10.14814/phy2.14556 · Cited by 13
“Recently, PAI1 was shown to induce fibroblast activation and αSMA expression (Pincha et al., 2018).”
BackgroundLuu, R. J., Hoefler, B. C., Gard, A. L., Ritenour, C. R., Rogers, M. T., Kim, E. S., Coppeta, J. R., Cain, B. P., Isenberg, B. C., Azizgolshani, H., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1160851 · Cited by 12
Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches
Yin, H., Li, R., Lu, L., & Yan, Q. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00953-0 · Cited by 11
Rayford, K. J., Cooley, A., Strode, A. W., Osi, I., Arun, A., Lima, M. F., Misra, S., Pratap, S., & Nde, P. N. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1083379 · Cited by 14
“However, several research findings have implicated ICAM1 in various fibrogenic diseases (Kuwahara et al., 2003; Tsoutsou et al., 2004; Richards et al., 2012; Pincha et al., 2018; Wen et al., 2022).”
BackgroundAkula, S., Tripathi, S. R., Franke, K., Wernersson, S., Babina, M., & Hellman, L. (2024) · Cells · doi:10.3390/cells13010098 · Cited by 11
Mohammadi, M., Kohan, L., Saeidi, M., Jazi, M. S., & Mohammadi, S. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2077217 · Cited by 10
Dias, A. B., de Oliveira, S. A., Cerri, P. S., & Sasso‐Cerri, E. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151873 · Cited by 9
The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis
Chen, X., Wu, C. F., Tang, F., Zhou, J., Mo, L., Li, Y., & He, J. (2025) · Advanced Science · doi:10.1002/advs.202505067 · Cited by 15
Atyakshin, D. A. (2018) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2018-7-3-100-112 · Cited by 9
Development and dysfunction of structural cells in eosinophilic esophagitis
Laky, K., & Frischmeyer‐Guerrerio, P. A. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.04.006 · Cited by 11
Polinas, M., Padrós, F., Merella, P., Prearo, M., Sanna, M. A., Marino, F., Burrai, G. P., & Antuofermo, E. (2021) · Animals · doi:10.3390/ani11061501 · Cited by 10
“Mast cell function in the pathogenesis of human fibrosis has been extensively investigated and different mechanisms of their action on fibroblasts have been defined, such as the piecemeal release of cytoplasmic vesicles in the interstitium or via the transfer of molecules by direct cell-to-cell contact (transgranulati…”
BackgroundZaarour, R. F., Saha, D., Dey, R., Dutta, A., Kumar, P., Rana, I., Pulianmackal, A. J., Rizvi, A., Misra, N., Breton, L., et al. (2022) · Experimental Dermatology · doi:10.1111/exd.14573 · Cited by 11
Self-citationMindin is essential for cutaneous fibrogenesis in a new mouse model of systemic sclerosisPreprint
Rana, I., Kataria, S., Tan, T. L., Hajam, E. Y., Kashyap, D., Saha, D., Ajnabi, J., Paul, S., Jayappa, S., Ananthan, A. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.26.477822 · Cited by 7
“This transgenic mouse recapitulates the expression pattern of Snail observed in human SSc skin (Figure 1b) and also develops dermal fibrosis (2), (17).”
BackgroundResultInfluentialSelf-citationTakahashi, T., Takahashi, T., & Asano, Y. (2025) · Biomedical Journal · doi:10.1016/j.bj.2025.100906 · Cited by 7
“PAI-1, induced by TGF-β stimulation, acts as a key mediator of mast cell infiltration into lesional skin and concurrently upregulates ICAM-1 expression on dermal fibroblasts, thereby facilitating mast cell adhesion [33,88].”
Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1
Chen, Y., Zhang, Z., Cheng, Y., Chen, X., Zhou, J., Wei, Z., Yao, H., Zhang, S., Kong, Q., Tang, H., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104018 · Cited by 4
“Besides, PAI-1 mediates fibroblast-mast cell interactions to drive the development of skin fibrosis [46].”
Saha, D., Annadorai, R. K., Thannimangalath, S., Shroff, N. P., Kataria, S., Dam, B., Dutta, A., Hegde, A., Hiwale, A. A., Ravula, V., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci177123 · Cited by 6
“Though Mindin or PAI1 play critical roles in fibrogenesis in Snail -tg skin, they are not required for vasculopathy (Supplemental Figure 3, C–”
Self-citationLuo, J., Li, M., Zhao, D., Chen, H., Huang, J., Sun, M., Zhu, Q., Guo, Q., Song, S., Yuan, Q., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116166 · Cited by 3
Shestakova, V. A., Smirnova, E. I., Atiakshin, D., Kisel, A. A., Koryakin, S. N., Litun, E. V., Saburov, V. O., Demyashkin, G. A., Lagoda, T. S., Yakimova, A. O., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051994 · Cited by 4
“This interaction is vital for the formation of a robust fibrous matrix that provides structural support for the new, regenerated tissue [47].”
Jing, T., Wu, T., Lu, Y., Ge, Y., Zhang, F., wang, Q., & He, P. (2023) · Electrochimica Acta · doi:10.1016/j.electacta.2023.142693 · Cited by 3
Molecular pathogenesis of fibrosis in systemic sclerosis
Jinnin, M. (2022) · Trends in Immunotherapy · doi:10.24294/ti.v6.i1.1453 · Cited by 2
“Epidermal cells in SSc lesional skin are involved in fibrosis through cytokine secretion[61].”
BackgroundBiomarkers in Systemic Sclerosis
Karsulovic, C., & Hojman, L. P. (2025) · Sclerosis · doi:10.3390/sclerosis3020011 · Cited by 2
“These findings highlight the potential of PAI-1 as a biomarker for disease activity in SSc, particularly concerning skin and pulmonary involvement [76].”
Mindin regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis
Kataria, S., Rana, I., Badarinath, K., Zaarour, R. F., Kansagara, G., Ahmed, S., Rizvi, A., Saha, D., Dam, B., Dutta, A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.173071 · Cited by 3
“We have previously reported that there is robust inflammation in the Snail -Tg skin (36, 49), which is substantially decreased in the absence of Mindin (15).”
Self-citationQUANTIFICAÇÃO DE MASTÓCITOS EM LESÕES REVERSÍVEIS E IRREVERSÍVEIS DO FÍGADO HUMANO
Paulo, B. E. D., & Rocha, L. B. (2019) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v23i2.2019.6790 · Cited by 2
Kataria, S., Rana, I., Badarinath, K., Zaarour, R. F., Kansagara, G., Zirmire, R. K., Dam, B., Kumar, P., Gulyani, A., & Jamora, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.17.492347 · Cited by 1
Self-citationCao, T., Tang, J., Zhou, D., Yao, C., Xu, J., Liu, Y., Feng, C., Shi, Y., Wang, M., Chao, W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.02.657200 · Cited by 2
Strattan, E., Palaniyandi, S., Kumari, R., Du, J., Hakim, N., Huang, T., Kesler, M., JENNINGS, C. D., Sturgill, J., & Hildebrandt, G. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/668236
González-Barrio, D., Diezma‐Díaz, C., Gutiérrez-Expósito, D., Tabanera, E., Jiménez‐Meléndez, A., Pizarro, M., González‐Huecas, M., Ferre, I., Ortega-Mora, L. M., & Álvarez-García, G. (2021) · Figshare · doi:10.6084/m9.figshare.15041010
González-Barrio, D., Diezma‐Díaz, C., Gutiérrez-Expósito, D., Tabanera, E., Jiménez‐Meléndez, A., Pizarro, M., González‐Huecas, M., Ferre, I., Ortega-Mora, L. M., & Álvarez-García, G. (2021) · Figshare · doi:10.6084/m9.figshare.15041004
González-Barrio, D., Diezma‐Díaz, C., Gutiérrez-Expósito, D., Tabanera, E., Jiménez‐Meléndez, A., Pizarro, M., González‐Huecas, M., Ferre, I., Ortega-Mora, L. M., & Álvarez-García, G. (2021) · Figshare · doi:10.6084/m9.figshare.15041007
Moideen, F. M., & Bhandary, Y. P. (2026) · Inflammation · doi:10.1007/s10753-026-02533-3
“PAI-1, hyperse-creted by EMT-derived fibroblasts, inhibits ECM turnover to promote collagen-rich scar deposition; keloid keratinocytes exhibit fibroblast-like phenotypes with upregulated PAI-1 under hypoxia [ 117, 118 ].”
Yuan, Z., Sun, Y., Kong, L., Yu, S.-S., Zheng, F., Yan, P., Liu, B., He, D., Zuo, Y., Lu, H., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202505076rr
Metadata
- Authors
- Pincha, N., Hajam, E. Y., Badarinath, K., Batta, S. P. R., Masudi, T., Dey, R., Andreasen, P., Kawakami, T., Samuel, R., George, R., Danda, D., Jacob, P. M., & Jamora, C.
- Affiliations
- Manipal Academy of Higher Education (IN)
- Institute for Stem Cell Biology and Regenerative Medicine (IN)
- National Centre for Biological Sciences (IN)
- Aarhus University (DK)
- La Jolla Institute for Immunology (US)
- Christian Medical College, Vellore (IN)
- Corresponding author
- Jamora, Colin
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-03-26
- Volume
- 128
- Issue
- 5
- Pages
- 1807-1819
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5919880
- OpenAlex
- W2790811974
- Cited by
- 70
- References
- 83
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 14 · 2019: 7 · 2018: 5
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology (BT/PR8738/AGR/36/770/2013, BT/PR5981/MED/31/181/2012;2013-2016)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5RO1AR053185-05)
- American Cancer Society (115457-RSG-08-164-01-DDC)
- University of California, San Diego (Hellman Faculty Fellowship)
- Indian Council of Medical Research (ICMR-SRF)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- plasminogen activator inhibitor-1, skin fibrosis, mast cell infiltration, snails, keratinocytes, ICAM-1, systemic sclerosis, fibrogenesis
- MeSH terms
- Animals, Cell Communication, Epidermis, Fibroblasts, Fibrosis, Mast Cells, Skin Diseases, Up-Regulation, Mice, Knockout, Intercellular Adhesion Molecule-1, Mice, Serpin E2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.